Triterpene saponosides from Lysimachia ciliata differentially attenuate invasive potential of prostate cancer cells

Chemico-Biological Interactions

Volumn 206, Issue 1, 2013, Pages 6-17

  Koczurkiewicz, Paulina ^a   Podolak, Irma ^a   Skrzeczyńska Moncznik, Joanna ^a   Sarna, Michał ^b   Wójcik, Katarzyna Anna ^a   Ryszawy, Damian ^a   Galanty, Agnieszka ^a   Lasota, Sławomir ^a   Madeja, Zbigniew ^a   Czyz, Jarosław ^a   Michalik, Marta ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Apoptosis; Cell elasticity; Cell motility; Proliferation; Prostate cancer; Triterpene saponosides

Indexed keywords

ANAGALLOSAPONIN IV; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CYTOCHROME C; DESGLUCOANAGALLOSIDE B; LYSIMACHIA CILIATA EXTRACT; MITOXANTRONE; PLANT EXTRACT; TRITERPENE SAPONOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL MOTILITY; CELLULAR SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; DNA CONTENT; DRUG ISOLATION; DRUG SELECTIVITY; DRUG SPECIFICITY; ELASTICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYSIMACHIA CILIATA; MEDICINAL PLANT; PROSTATE CANCER; PROTEIN SECRETION; TUMOR INVASION;

AFM; ANAGALLOSAPONIN IV; ANNEXIN V; ANV; APOPTOSIS; ATOMIC FORCE MICROSCOPY; CELL ELASTICITY; CELL MOTILITY; CIL-1; CIL-2; DESGLUCOANAGALLOSIDE B; FBS; FETAL BOVINE SERUM; PI; PROLIFERATION; PROPIDIUM IODIDE; PROSTATE CANCER; REACTIVE OXYGEN SPECIES; ROS; TRITERPENE SAPONOSIDES;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MALE; MOLECULAR STRUCTURE; NEOPLASM INVASIVENESS; PRIMULACEAE; PROSTATIC NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

LYSIMACHIA CILIATA;

EID: 84883173151     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.08.003     Document Type: Article

References (71)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2001 57 70 (Pubitemid 30046295)
2. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
3. E. Bremer, G. van Dam, B.J. Kroesen, L. de Leij, and W. Helfrich Targeted induction of apoptosis for cancer therapy: current progress and prospects Trends Mol. Med. 12 2006 382 393 (Pubitemid 44164637)
4. M. Frezza, S. Schmitt, and P.Q. Dou Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy Curr. Top. Med. Chem. 11 2011 2888 2905
5. A. Yagoda, and D. Petrylak Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer Semin. Oncol. 22 1995 42 60
6. A. Hurria, K. Togawa, S.G. Mohile, C. Owusu, H.D. Klepin, C.P. Gross, S.M. Lichtman, A. Gajra, S. Bhatia, V. Katheria, S. Klapper, K. Hansen, R. Ramani, M. Lachs, F.L. Wong, and W.P. Tew Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study J. Clin. Oncol. 29 2011 3457 3465
7. A.W. Hsing, and A.P. Chokkalingam Prostate cancer epidemiology Front. Biosci. 11 2006 1388 1413 (Pubitemid 43253429)
8. C.Z. Wang, G. Du, Z. Zhang, X.D. Wen, T. Calway, Z. Zhen, M.W. Musch, M. Bissonnette, E.B. Chang, and C.S. Yuan Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer Int. J. Oncol. 40 2012 1970 1976
9. S. Gupta Prostate cancer chemoprevention: current status and future prospects Toxicol. Appl. Pharmacol. 224 2007 369 376 (Pubitemid 47575668)
10. G.A. Saxe, J.M. Major, L. Westerberg, S. Khandrika, and T.M. Downs Biological mediators of effects of diet and stress reduction on prostate cancer Integr. Cancer Ther. 7 2008 130 138
11. S. Arcangeli, V. Pinzi, and G. Arcangeli Epidemiology of prostate cancer and treatment remarks World J. Radiol. 4 2012 241 246
12. E.D. Crawford, and T. Connor Proposed update on substaging metastatic prostate cancer Urology 74 2009 237
13. B.J. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 2001 34 45 (Pubitemid 33741879)
14. T. Ichikawa, H. Suzuki, T. Ueda, A. Komiya, T. Imamoto, and S. Kojima Hormone treatment for prostate cancer: current issues and future directions Cancer Chemother. Pharmacol. 56 2005 58 63
15. S.J. Freedland, and W.J. Aronson Dietary intervention strategies to modulate prostate cancer risk and prognosis Curr. Opin. Urol. 19 2009 263 267
16. K. Miȩkus, and Z. Madeja Genistein inhibits the contact-stimulated migration of prostate cancer cells Cell. Mol. Biol. Lett. 12 2007 348 361
17. M. Czernik, J. Sroka, Z. Madeja, and J. Czyz Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations Cell. Mol. Biol. Lett. 13 2008 327 338
18. C. Spagnuolo, M. Russo, S. Bilotto, I. Tedesco, B. Laratta, and G.L. Russo Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia Ann. N.Y. Acad. Sci. 1259 2012 95 103
19. S.M. Kim, S.Y. Lee, J.S. Cho, S.M. Son, S.S. Choi, Y.P. Yun, H.S. Yoo, D.Y. Yoon, K.W. Oh, S.B. Han, and J.T. Hong Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB Eur. J. Pharmacol. 631 2010 1 9
20. S. Man, W. Gao, Y. Zhang, L. Huang, and C. Liu Chemical study and medical application of saponins as anti-cancer agents Fitoterapia 81 2010 703 714
21. B. Klimek Hydroxycinnamoyl ester glycosides and saponins from flowers of Verbascum phlomoides Phytochemistry 43 1996 1281 1284 (Pubitemid 27104596)
22. S.A. Nag, J.J. Qin, W. Wang, M.H. Wang, H. Wang, and R. Zhang Ginsenosides as anticancer agents: in vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action Front. Pharmacol. 3 2012 25
23. K.W. Glombitza, and H. Kurth The structures of some triterpene saponines from Anagallis arvensis Planta Med. 53 1987 548 555
24. N. Shoji, A. Umeyama, K. Yoshikawa, and S. Arihara Structures of anagallosaponins I-V and their companion substances from Anagallis arvensis L Chem. Pharm. Bull. 42 1994 1750 1755 (Pubitemid 24315479)
25. M.M. Abdel-Gawad, S.M. El-Amin, H. Ohigashi, Y. Watanabe, N. Takeda, H. Sugiyama, and M. Kawanaka Molluscicidal saponins from Anagallis arvensis against schistosome intermediate hosts Jpn. J. Infect. Dis. 53 2000 17 19 (Pubitemid 30312762)
26. I. Podolak, P. Koczurkiewicz, A. Galanty, and M. Michalik Cytotoxic triterpene saponins from the underground parts of six Lysimachia L. species Biochem. Syst. Ecol. 47 2013 116 120
27. A. van Bokhoven, M. Varella-Garcia, C. Korch, W.U. Johannes, E.E. Smith, H.L. Miller, S.K. Nordeen, G.J. Miller, and M.S. Lucia Molecular characterization of human prostate carcinoma cell lines Prostate 57 2003 205 225 (Pubitemid 37267805)
28. J.P. Campbell, A.R. Merkel, S.K. Masood-Campbell, F. Elefteriou, and J.A. Sterling Models of bone metastasis J. Vis. Exp. 4 2012 4260 4265
29. I. Podolak, A. Galanty, and D. Sobolewska Saponins as cytotoxic agents: a review Phytochem. Rev. 9 2010 425 474
30. V.V. Belousov, F. Fradkow, K.A. Lukyanov, D.B. Staroverov, K.S. Shakhbazov, A.V. Terskikh, and S. Lukyanov Genetically encoded fluorescent indicator for intracellular hydrogen peroxide Nat. Methods 3 2006 281 286
31. Z. Madeja, K. Miȩkus, J. Sroka, M.B. Djamgoz, and W. Korohoda Homotypic cell-cell contacts stimulate the motile activity of rat prostate cancer cells BJU Int. 88 2001 776 786
32. M. Radmacher, M. Fritz, C.M. Kacher, J.P. Cleveland, and P.K. Hansma Measuring the viscoelastic properties of human platelets with the atomic force microscope Biophys. J. 70 1996 556 567 (Pubitemid 26021495)
33. J.L. Hutter, and J. Bechhoefer Calibration of atomic-force microscope tips Rev. Sci. Instrum. 64 1993 1868 1873
34. A. Touhami, B. Nysten, and Y.F. Dufrene Nanoscale mapping of the elasticity of microbial cells by atomic force microscopy Langmuir 19 2003 4539 4543
35. S. Gairola, V. Gupta, P. Bansal, R. Singh, and M. Maithani Herbal antitussives and expectorans - a review Int. J. Pharm. Sci. Rev. Res. 5 2010 5 9
36. R. Rivero, A. Zabala, R. Gianneechini, J. Gil, and J. Moraes Anagallis arvensis poisoning in cattle and sheep in Uruguay Vet. Human Toxicol. 43 2001 27 30 (Pubitemid 32114145)
37. Ch. Bachran, H. Durkop, M. Sutherland, D. Bachran, C. Müller, A. Weng, M.F. Melzig, and H. Fuchs Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way J. Immunother. 32 2009 713 725
38. H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M.F. Melzig, M. Sutherland, and C. Bachran Saponins as tool for improved targeted tumor therapies Curr. Drug Targets 10 2009 140 151
39. C. Bachran, A. Weng, D. Bachran, S.B. Riese, N. Schellmann, M.F. Melzig, and H. Fuchs The distribution of saponins in vivo affects their synergy with chimeric toxins against tumours expressing human epidermal growth factor receptors in mice Br. J. Pharmacol. 159 2010 345 352
40. K. Mujoo, V. Haridas, J.J. Hoffmann, G.A. Wächter, L.K. Hutter, Y. Lu, M.E. Blake, G.S. Jayatilake, D. Bailey, G.B. Mills, and J.U. Gutterman Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis Cancer Res. 61 2001 5486 5490 (Pubitemid 32694931)
41. A.A. Ellington, M. Berhow, and K.W. Singletary Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins Carcinogenesis 26 2005 159 167 (Pubitemid 40207711)
42. A. Ivanowa, J. Serly, D. Dinchev, I. Ocsovszki, I. Kostowa, and J. Molnar Screening of some saponins and phenolic components of Tribulus terrestris and smilax excelsa as MDR modulators In Vivo 23 2009 545 550
43. S. Cao, P. Brodie, M. Callmander, R. Randrianaivo, J. Razafitsalama, E. Rakotobe, V.E. Rasamison, K. TenDyke, Y. Shen, E.M. Suh, and D.G.I. Kingston Antiproliferative triterpenoid saponins of Dodonaea viscosa from the Madagascar dry forest J. Nat. Prod. 72 2009 1705 1707
44. J. Balsevich, I. Ramirez-Erosa, R.A. Hickie, D.M. Dunlop, G.G. Bishop, and L.K. Deibert Antiproliferative activity of Saponaria vaccaria constituents and related compounds Fitoterapia 83 2012 170 181
45. I. Podolak, P. Koczurkiewicz, M. Michalik, A. Galanty, P. Zajdel, and Z. Janeczko A new cytotoxic triterpene saponin from Lysimachia nummularia L Carbohydr. Res. 375 2013 16 20
46. A.G. Musende, A. Eberding, C. Wood, H. Adomat, L. Fazli, A. Hurtado-Coll, W. Jia, M.B. Bally, and E.T. Guns Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy Cancer Chemother. Pharmacol. 64 2009 1085 1095
47. Y.X. Chang, Y.G. Sun, J. Li, Q.H. Zhang, X.R. Guo, B.L. Zhang, H. Jin, and X.M. Gao The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 12 2012 71 75
48. P.D. Violette, and F. Saad Chemoprevention of prostate cancer: myths and realities J. Am. Board Fam. Med. 25 2012 111 119
49. L. Reddivari, J. Vanamala, S.H. Safe, and J.C. Miller The bioactive compounds alpha-chaconine and garlic acid in potato extracts decrease survival and induces apoptosis LNCaP and PC-3 prostate cancer cells Nutr. Cancer 5 2010 601 610
50. J.H. Lee, E.K. Oh, H.D. Cho, J.Y. Kim, M.K. Lee, and K.I. Seo Crude saponins from Platycodon grandiflorum indu ce apoptotic cell heath in RC-58T/h/SA 4 prostate cancer cells through the activation of caspase cascades and apoptosis inducing factor Oncol. Rep. 4 2013 421 428
51. Y. Ji, C. Ji, L. Yue, and H. Xu Saponins isolated from Asparagus induce apoptosis in human hepatoma cell line HepG2 through a mitochondria-mediated pathway Curr. Oncol. 19 2012 1 9
52. I. Podolak, M. Elas, and K. Cieszka In vitro antifungal and cytotoxic activity of triterpene saponosides and quinoid pigments from Lysimachia vulgaris L Phytother. Res. 12 1998 70 73
53. A. Galanty, M. Michalik, L. Sȩdek, and I. Podolak The influence of LTS-4, a saponoside from Lysimachia thyrsiflora L. on human skin fibroblasts and human melanoma cells Cell. Mol. Biol. Lett. 13 2008 585 598
54. S.C. Bang, J.H. Lee, G.Y. Song, D.H. Kim, M.Y. Yoon, and B.Z. Ahn Antitumor activity of Pulsatilla koreana saponins and their structure-activity relationship Chem. Pharm. Bull. 53 2005 1451 1454
55. P. Trouillas, C. Corbiere, B. Liagre, J.L. Beney, and J.L. Duroux Structure-function relationship for saponin effects on cell cycle arrest and apoptosis in the human 1547 osteosarcoma cells: a molecular modeling approach of natural molecules structurally close to diosgenin Bioorg. Med. Chem. 13 2005 1141 1149 (Pubitemid 40164598)
56. P. Avato, R. Bucci, A. Tava, C. Vitali, A. Rosato, Z. Bialy, and M. Jurzysta Antimicrobial activity of saponins from Medicago sp.: structure-activity relationship Phytother. Res. 20 2006 454 457 (Pubitemid 43953397)
57. R. Collins, R. Trowman, G. Norman, K. Light, A. Birtle, E. Fenwick, S. Palmer, and R. Riemsma A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer Br. J. Cancer 95 2006 457 462 (Pubitemid 44232554)
58. Y.M. Toh, and K.T. Li Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway Clin. Cancer Res. 17 2011 5026 5037
59. E. Kingwell, M. Koch, B. Leung, S. Isserow, J. Geddes, P. Rieckmann, and H. Tremlett Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS Neurology 74 2010 1822 1826
60. S. Kumar, and V.M. Weaver Mechanics, malignancy, and metastasis: the force journey of a tumor cell Cancer Metastasis Rev. 28 2009 113 127
61. M. Lekka, K. Pogoda, J. Gostek, O. Klymenko, S. Prauzner-Bechcicki, J. Wiltowska-Zuber, J. Jaczewska, J. Lekki, and Z. Stachura Cancer cell recognition-mechanical phenotype Micron 43 2012 1259 1266
62. E.J. Hagedorn, and D.R. Sherwood Cell invasion through basement membrane: the anchor cell breaches the barrier Curr. Opin. Cell Biol. 23 2011 589 596
63. L. Bastatas, D. Martinez-Marin, J. Matthews, J. Hashem, Y.J. Lee, S. Sennoune, S. Filleur, R. Martinez-Zaguilan, and S. Park AFM nano-mechanics and calcium dynamics of prostate cancer cells with distinct metastatic potential Biochim. Biophys. Acta 2012 1820 1111 1120
64. S. Suresh Biomechanics and biophysics of cancer cells Acta Biomater. 3 2007 413 438 (Pubitemid 46865787)
65. E.S. Cross, J. Yu-Sheng, J. Tondre, R. Wong, R. JianYu, and J.K. Gimzewski AFM-based analysis of human metastatic cancer cells Nanotechnology 19 2008 384003 384011
66. Q.S. Li, G.Y.H. Lee, C.N. Ong, and C.T. Lim AFM indentation study of breast cancer cells Biochem. Biophys. Res. Commun. 374 2008 609 613
67. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
68. I. Bechyne, K. Szpak, Z. Madeja, and J. Czyz Functional heterogeneity of non-small lung adenocarcinoma cell sub-populations Cell Biol. Int. 36 2012 99 103
69. Y.L. Jiang, and Z.P. Liu Natural products as anti-invasive and anti-metastatic agents Curr. Med. Chem. 18 2011 808 829
70. R. Leth-Larsen, M.G. Terp, A.G. Christensen, D. Elias, T. Kühlwein, O.N. Jensen, O.W. Petersen, and H.J. Ditzel Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis Mol. Med. 4 2012 324 336
71. J. Czyz, K. Szpak, and Z. Madeja The role of connexins in prostate cancer promotion and progression Nat. Rev. Urol. 21 2012 274 282